Sarepta Therapeutics, Inc. - stock earnings
SRPT Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | 0.73 / -0.07 | - | 413.5 million / 380.7 million | - |
| July 31, 2024 BeforeMarket | - / - | 365.6 million | - / 384.4 million | 435.0 million |
SRPT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 36.1 million USD | 413.5 million USD |
| 2023Q4 | 45.7 million USD | 396.8 million USD |
| 2023Q3 | -40.9 million USD | 331.8 million USD |
| 2023Q2 | -23.9 million USD | 261.2 million USD |
| 2023Q1 | -516.8 million USD | 253.5 million USD |
| 2022Q4 | -109.2 million USD | 258.4 million USD |
| 2022Q3 | -257.7 million USD | 230.3 million USD |
| 2022Q2 | -231.5 million USD | 233.5 million USD |
| 2022Q1 | -105.0 million USD | 210.8 million USD |
| 2021Q4 | -122.0 million USD | 201.5 million USD |
| 2021Q3 | -48.1 million USD | 189.4 million USD |
| 2021Q2 | -81.4 million USD | 164.1 million USD |
| 2021Q1 | -167.3 million USD | 146.9 million USD |
| 2020Q4 | -189.3 million USD | 145.1 million USD |
| 2020Q3 | -196.5 million USD | 143.9 million USD |
| 2020Q2 | -150.8 million USD | 137.4 million USD |
| 2020Q1 | -17.5 million USD | 113.7 million USD |
| 2019Q4 | -235.7 million USD | 100.1 million USD |
| 2019Q3 | -126.3 million USD | 99.0 million USD |
| 2019Q2 | -276.4 million USD | 94.7 million USD |
| 2019Q1 | -76.6 million USD | 87.0 million USD |
| 2018Q4 | -140.9 million USD | 84.4 million USD |
| 2018Q3 | -76.4 million USD | 78.5 million USD |
| 2018Q2 | -109.3 million USD | 73.5 million USD |
| 2018Q1 | -35.4 million USD | 64.6 million USD |
| 2017Q4 | -24.0 million USD | 57.3 million USD |
| 2017Q3 | -47.7 million USD | 46.0 million USD |
| 2017Q2 | -63.0 million USD | 35.0 million USD |
| 2017Q1 | 84.1 million USD | 16.3 million USD |
| 2016Q4 | -88.5 million USD | 5.4 million USD |
| 2016Q3 | -56.7 million USD | ? USD |
| 2016Q2 | -62.3 million USD | ? USD |
| 2016Q1 | -59.8 million USD | ? USD |
| 2015Q4 | -64.7 million USD | 1.3 million USD |
| 2015Q3 | -51.9 million USD | ? USD |
| 2015Q2 | -41.9 million USD | ? USD |
| 2015Q1 | -61.6 million USD | ? USD |
| 2014Q4 | -44.4 million USD | 27000 USD |
| 2014Q3 | -29.2 million USD | 1.1 million USD |
| 2014Q2 | -33.9 million USD | 2.6 million USD |
| 2014Q1 | -28.3 million USD | 6.1 million USD |
| 2013Q4 | -8.8 million USD | 2.6 million USD |
| 2013Q3 | -42.0 million USD | 4.2 million USD |
| 2013Q2 | -19.1 million USD | 3.0 million USD |
| 2013Q1 | -42.1 million USD | 4.5 million USD |
| 2012Q4 | -62.1 million USD | 7.3 million USD |
| 2012Q3 | -49.6 million USD | 7.6 million USD |
| 2012Q2 | 8.0 million USD | 11.2 million USD |
| 2012Q1 | -17.7 million USD | 11.2 million USD |
| 2011Q4 | -1.4 million USD | 13.6 million USD |
| 2011Q3 | -4.0 million USD | 7.5 million USD |
| 2011Q2 | 1.3 million USD | 11.6 million USD |
| 2011Q1 | 1.8 million USD | 14.3 million USD |
| 2010Q4 | -7.6 million USD | 15.5 million USD |
| 2010Q3 | -7.3 million USD | 8.7 million USD |
| 2010Q2 | -16.7 million USD | 4.0 million USD |
| 2010Q1 | -584000 USD | 1.2 million USD |
| 2009Q4 | 3.5 million USD | 5.1 million USD |
| 2009Q3 | -8.1 million USD | 6.3 million USD |
| 2009Q2 | -19.7 million USD | 2.9 million USD |
| 2009Q1 | -927000 USD | 3.2 million USD |
| 2008Q4 | -1.1 million USD | 5.5 million USD |
| 2008Q3 | -6.0 million USD | 5.2 million USD |
| 2008Q2 | -1.8 million USD | 5.0 million USD |
| 2008Q1 | -15.0 million USD | 5.6 million USD |
| 2007Q4 | -4.1 million USD | 5.2 million USD |
| 2007Q3 | -7.0 million USD | 2.9 million USD |
| 2007Q2 | -8.5 million USD | 2.4 million USD |
| 2007Q1 | -9.7 million USD | 536042 USD |
| 2006Q4 | -8.3 million USD | 17519 USD |
| 2006Q3 | -6.8 million USD | 13252 USD |
| 2006Q2 | -6.9 million USD | 18558 USD |
| 2006Q1 | -9.1 million USD | 65962 USD |
| 2005Q4 | -4.6 million USD | 1.4 million USD |
| 2005Q3 | -1.7 million USD | 3.3 million USD |
| 2005Q2 | -4.9 million USD | 39317 USD |
| 2005Q1 | -5.5 million USD | 45192 USD |
| 2004Q4 | -5.0 million USD | 285588 USD |
| 2004Q3 | -5.1 million USD | 9151 USD |
| 2004Q2 | -7.1 million USD | 36271 USD |
| 2004Q1 | -7.5 million USD | 99451 USD |
| 2003Q4 | -3.1 million USD | 135181 USD |
| 2003Q3 | -4.6 million USD | 414352 USD |
| 2003Q2 | -3.5 million USD | 162410 USD |
| 2003Q1 | -3.4 million USD | 257923 USD |
| 2002Q4 | -4.0 million USD | 169206 USD |
| 2002Q3 | -7.1 million USD | 232192 USD |
| 2002Q2 | -10.5 million USD | 197691 USD |
| 2002Q1 | -4.6 million USD | 295309 USD |
| 2001Q4 | -4.6 million USD | 295309 USD |
| 2001Q3 | -15.6 million USD | 307549 USD |
| 2001Q2 | -3.5 million USD | 87264 USD |
| 2001Q1 | -3.2 million USD | 15980 USD |
| 2000Q4 | -3.0 million USD | 25000 USD |
| 2000Q3 | -2.3 million USD | 122215 USD |
| 2000Q2 | -2.8 million USD | 18250 USD |
| 2000Q1 | -1.1 million USD | 1.1 million USD |
| 1999Q4 | -2.4 million USD | ? USD |
| 1999Q3 | -2.2 million USD | 100000 USD |
| 1999Q2 | -2.0 million USD | 100000 USD |
| 1999Q1 | -1.7 million USD | 100000 USD |
| 1998Q4 | -2.4 million USD | 100000 USD |
| 1998Q3 | -21.3 million USD | 100000 USD |
| 1998Q2 | -1.7 million USD | 100000 USD |
| 1998Q1 | -1.4 million USD | 100000 USD |
| 1997Q4 | -800000 USD | ? USD |
| 1997Q3 | -900000 USD | 100000 USD |
| 1997Q2 | -1.3 million USD | 100000 USD |
| 1997Q1 | -300000 USD | 100000 USD |
| 1996Q4 | -670000 USD | 10000 USD |
| 1996Q3 | -580000 USD | 20000 USD |
| 1996Q2 | -580000 USD | ? USD |
| 1996Q1 | -250000 USD | ? USD |
SRPT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -536.0 million USD | 1.2 billion USD |
| 2022 | -703.5 million USD | 933.0 million USD |
| 2021 | -418.8 million USD | 701.9 million USD |
| 2020 | -554.1 million USD | 540.1 million USD |
| 2019 | -715.1 million USD | 380.8 million USD |
| 2018 | -361.9 million USD | 301.0 million USD |
| 2017 | -50.7 million USD | 154.6 million USD |
| 2016 | -267.3 million USD | 5.4 million USD |
| 2015 | -220.0 million USD | 1.3 million USD |
| 2014 | -135.8 million USD | 9.8 million USD |
| 2013 | -112.0 million USD | 14.2 million USD |
| 2012 | -121.3 million USD | 37.3 million USD |
| 2011 | -2.3 million USD | 47.0 million USD |
| 2010 | -32.2 million USD | 29.4 million USD |
| 2009 | -25.2 million USD | 17.6 million USD |
| 2008 | -24.0 million USD | 21.3 million USD |
| 2007 | -27.2 million USD | 11.0 million USD |
| 2006 | -31.1 million USD | 115291 USD |
| 2005 | -16.7 million USD | 4.8 million USD |
| 2004 | -24.8 million USD | 430461 USD |
| 2003 | -14.6 million USD | 969866 USD |
| 2002 | -29.4 million USD | 836784 USD |
| 2001 | -26.9 million USD | 706102 USD |
| 2000 | -9.2 million USD | 1.3 million USD |
| 1999 | -8.3 million USD | 100000 USD |
| 1998 | -26.7 million USD | 200000 USD |
| 1997 | -3.6 million USD | 100000 USD |
| 1996 | -2.1 million USD | 100000 USD |
| 1995 | -2.6 million USD | 100000 USD |
SRPT
Price: $133.89
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.80 USD
P/E Ratio: -15.83
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 366531
Ebitda: -43.3 millionMarket Capitalization: 12.6 billion